Keywords: beats, forecasts, 2nd, qtr, earnings, second, quarter
J&J beats forecasts with 2nd qtr earnings
Article | 20 July 2000
For the second quarter of 2000, Johnson & Johnson posted sales of $7.5billion and net earnings of $1.3 billion, increases of 7.7% and 14.3% respectively ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
